losartan has been researched along with Bladder Disorder, Neurogenic in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Excerpt | Relevance | Reference |
---|---|---|
"To investigate the effect of losartan on preventing bladder fibrosis and protecting renal function in rats with neurogenic paralysis bladder (NPB)." | 8.02 | Losartan prevents bladder fibrosis and protects renal function in rat with neurogenic paralysis bladder. ( Bauer, SB; Chen, Y; He, YL; Ji, FP; Liu, EP; Ma, Y; Pu, QS; Wang, QW; Wang, Y; Wen, JG; Wen, YB; Xing, D; Yang, XH; Zhai, RQ, 2021) |
"To investigate the effect of losartan on preventing bladder fibrosis and protecting renal function in rats with neurogenic paralysis bladder (NPB)." | 4.02 | Losartan prevents bladder fibrosis and protects renal function in rat with neurogenic paralysis bladder. ( Bauer, SB; Chen, Y; He, YL; Ji, FP; Liu, EP; Ma, Y; Pu, QS; Wang, QW; Wang, Y; Wen, JG; Wen, YB; Xing, D; Yang, XH; Zhai, RQ, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
He, YL | 1 |
Wen, JG | 1 |
Pu, QS | 1 |
Wen, YB | 1 |
Zhai, RQ | 1 |
Chen, Y | 1 |
Ma, Y | 1 |
Liu, EP | 1 |
Xing, D | 1 |
Ji, FP | 1 |
Yang, XH | 1 |
Wang, QW | 1 |
Wang, Y | 1 |
Bauer, SB | 1 |
1 other study available for losartan and Bladder Disorder, Neurogenic
Article | Year |
---|---|
Losartan prevents bladder fibrosis and protects renal function in rat with neurogenic paralysis bladder.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Fibrosis; Losartan; Male; | 2021 |